News

New Delhi, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The global generic pharmaceuticals contract manufacturing market is anticipated to be worth US$ 135.43 billion by 2033, growing at a CAGR of 6.15% ...
TORONTO, Sept. 28, 2017 /PRNewswire/ -- Impopharma Inc. ("Impopharma") today announced that it has entered into an asset purchase, license, and commercialization agreement with Breckenridge ...
DUBLIN--(BUSINESS WIRE)--Altan Pharma Limited (“Altan”), an Irish specialty pharmaceutical company, today announced that it has signed a licensing agreement to commercialise a generic version ...